Others titles

  • Psychiatric Hospital Compare Data
  • Inpatient Hospital Quality Measures
  • CMS Quality Measures Data
  • IPQRF Program Quality Measures
  • Inpatient Psychiatric Hospital Facility Quality Measures
  • Inpatient Psychiatric Hospital Facility Quality Reporting Program

Keywords

  • Quality Reporting Programs
  • Quality Reporting Payments
  • Quality of Care Information
  • Eligible Psychiatric Hospitals
  • Psychiatric Hospital
  • Psychiatric Services
  • CMS Hospital Compare
  • Psychiatric Hospital Facilities

Inpatient Psychiatric Hospital Facility Quality Measures by National

This dataset includes the psychiatric facilities that are eligible for the Inpatient Psychiatric Facility Quality Reporting (IPFQR) program are required to meet all program requirements, otherwise their Medicare payments may be reduced. It contains national data for the hospitals in United States for several inpatient psychiatric facility quality measures.

Log in to download
Complexity

Get The Data

For getting access to data download links please read and accept the end-user license agreement.
Your Data License
  • Research
    Non-Commercial, Share-Alike, Attribution Free Forever
  • Commercial
    Commercial Use, Remix & Adapt, White Label Log in to download

John Snow Labs Standard End User License Agreement

Last updated:January 20, 2021

This Standard End User License Agreement (“EULA”) applies to customers of John Snow Labs Inc. (as defined below), using any product of John Snow Labs Inc. on John Snow Labs Marketplace as defined below (hereinafter referred to “you”) and John Snow Labs Inc., a Delaware corporation (“John Snow Labs”, “we” or “us”).

By downloading, installing, and/or using (as applicable) any Product of John Snow Labs (as defined below), you automatically agree to be bound by, and use our Products in compliance with, this EULA. This EULA, together with additional terms and conditions and/or policies referenced herein or located on https://www.johnsnowlabs.com and/or conveyed to you by John Snow Labs, is a legally binding contract between you and John Snow Labs.

PLEASE READ THIS EULA CAREFULLY BEFORE PURCHASING, INSTALLING OR USING OUR PRODUCTS MADE AVAILABLE ON JOHN SNOW LABS MARKETPLACE.

We may make changes to this EULA from time to time. When we do so, we will revise the “last updated” date given above. The then-current version of this EULA will supersede all earlier versions. You agree that your continued use of our Products after such changes have been published to our EULA will constitute your acceptance of such revised EULA.

Definitions

“John Snow Labs Data Library” means a data library located at https://www.johnsnowlabs.com;

“Products” means products and services of John Snow Labs that you download and use from listings in John Snow Labs Data Library;

Important Notice

By installing and using our Products, you acknowledge that the use of the Products can be subject to the restrictions and controls imposed by United States export regulations.

You represent and warrant that you do not intend to use the Products for any purpose prohibited by United States export regulations, including, without limitation, terrorism, cyber-attacks, cyber-crimes, money-laundering, industrial espionage, or nuclear, chemical or biological weapons proliferation. Further, you represent and warrant that you are not listed as a denied party on any list governing United States exports.

Eligibility

Our Products can be used by an individual, business or other legal entity, or both. If you are entering into this EULA, or using the Products, on behalf of a company or other legal entity, you represent that you have the authority to bind such entity to this EULA, in which case “you” shall refer to such entity.

In the event you have entered into a separate written agreement with John Snow Labs regarding the Products that contemplates terms that are inconsistent with this EULA, the written agreement shall control and this EULA will not apply to you to the extent inconsistent with such written agreement, or, if such written agreement is contemplated to be in lieu of this EULA, then this EULA shall not apply at all.

Your Access and Use

Subject to your compliance with this EULA, as well as any other applicable policies, John Snow Labs grants you non-exclusive, non-transferable, license to install, access to, modify, and use of, the Products worldwide (subject to applicable export laws) during the term of this EULA (as described below) solely for research, private study and personal use of Products.

This license is personal to you, and you may not resell our Products, permit other users access to our Products through your account. Your right to use our Products is limited by all terms and conditions set forth in this EULA.

Except for your pre-existing rights and this license granted to you, we and our licensors retain all rights, titles and interests in and to our Products, all related intellectual property rights, including trademarks (whether registered or pending), domain and business names. Our Products are protected by applicable intellectual property laws, including United States copyright law and international treaties.

Except for the foregoing license, you have no other rights in the Products and you may not modify, edit, copy, reproduce, create derivative works of, reverse engineer, alter, enhance or in any way exploit the Products in any manner. If you breach any of this EULA, the above license will terminate automatically.

You will be deemed to have taken any action that you permit, assist or facilitate any person or entity to take related to this EULA, your content or use of the Products. You are responsible for end users’ use of your content and the Products. You will ensure that all end users comply with your obligations under this EULA and that the terms of your agreement with each end user are consistent with this EULA. If you become aware of any violation of your obligations under this EULA caused by an end user, you will immediately suspend access to your content and the Products by such end user. We do not provide any support or services to end users unless we have a separate agreement with you or an end user obligating us to provide such support or services.

Restrictions

You will access or use our Products solely via John Snow Labs Data Library.

Except as otherwise explicitly provided in this EULA or as may be expressly permitted by applicable law, you will not, and will not permit or authorize any third party to:

  1. reproduce, modify, translate, enhance, decompile, disassemble, reverse engineer or create derivative works of any of our Products or its technological features or measures;
  2. rent, lease, sell, resell, loan, distribute, or sublicense access to any of our Products;
  3. circumvent or disable any security or technological features or measures of our Products;
  4. use our intellectual property rights without our express prior written authorization;
  5. use our Products for more than one trial period, unless the trial period is extended by John Snow Labs’ prior written permit;
  6. use our Products with an intent to build a competitive product or service, or copy or substantially copy any ideas, features, functions, organization, structure, application program interface, graphics, or user interface of the Products;
  7. store, copy, modify, distribute, or resell any of the information; audio, visual, and audiovisual works, or other content made available on our Products (collectively, “Content”) or compile or collect any Content as part of a database or other work;
  8. use any automated tool (e.g., robots, spiders) to access or use our Products, or to store, copy, modify, distribute, or resell any Content;
  9. circumvent or disable any rights management, usage rules, or other security features of our Products;
  10. use our Products in a manner that overburdens, or that threatens the integrity, performance, or availability of, our Products; or
  11. remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of our Products or any Content.

Fees and Taxes

Your use of the Products is subject to our fees. All fees are given on our website https://www.johnsnowlabs.com. Except as set forth in this EULA, the fees are non-refundable. We are entitled to revise our fees from time to time.

The fees exclude any federal, state or local taxes, VAT, GST, or similar taxes. You are responsible for identification and payment of all taxes as required by applicable law.

Term and Termination

This EULA will become effective as of the date of your order of Products and shall be in effect until terminated.

John Snow Labs may suspend or terminate your right to use our Products, if you or your end user’s use of the Products:

  1. is in breach of this EULA;
  2. poses a security risk to our Products;
  3. could adversely impact our systems, the Products or other customers;
  4. could subject us, our affiliates, or any third party to liability; or
  5. could be fraudulent.

We may also suspend or terminate your right to use our Products, if you fail to perform your payment obligations, or you have ceased to operate in the ordinary course, made an assignment for the benefit of creditors or similar disposition of your assets, or become the subject of any bankruptcy, reorganization, liquidation, dissolution or similar proceeding.

We may also suspend or terminate your right to use our Products without any reason upon a relevant 30 days’ written notice to you and will refund the unused fees pre-paid by you for access to the Products for the affected time period (if any). Where your access is suspended or terminated by the breach of this EULA or applicable laws, John Snow Labs will will not provide, or be liable for, any refund.

You will cease use of the Products during any period of suspension, or upon termination of this EULA.

All provisions which by their nature are intended to survive termination shall survive termination of this EULA.

Support

If applicable to your Product, John Snow Labs will provide you with the support services. If you use a trial access, support services are excluded. Under this EULA, our support services exclude any installation, training, maintenance services (including any error corrections, bug fixes, or new releases), technical assistance, consulting services, or other services of any kind. Such services are provided at John Snow Labs’ discretion.

From time to time John Snow Labs can perform updates to our software. If available, such updates may include bug fixes, new features and/or enhancements. You are solely responsible for deploying such updates at your own risk and liability.

Access to our Products

We do not provide you with the equipment to access our Products. You are responsible for all fees charged by third parties related to your access and use of our Products (e.g., charges by Internet service providers).

You are responsible for monitoring your use of the Products, including payment of all fees and/or taxes related to such access and use. You agree that John Snow Labs is permitted to request and you hereby consent to provide John Snow Labs information related to your use of the Products for auditing purposes.

You also certify that you are legally permitted to use the Products, and take full responsibility for the selection and use of the Products. This EULA is void where prohibited by law, and the right to use the Products is revoked in such jurisdictions. John Snow Labs makes no claim that the Products may be lawfully used outside of the United States. If you use the Products from outside of the United States, you do so at your own risk and you are responsible for compliance with the laws of jurisdiction.

Privacy Policy

We may collect, store and receive personal and other information about you through our Products. Our collection and use of this information is governed by our Privacy Policy available at https://www.JohnSnowLabs.com/privacy/ which may be amended from time to time.

Links and Third Party Content

Our Products may display, or contain links to, third party products, services, and websites. Any opinions, advice, statements, services, offers, or other information that constitutes part of the content expressed, authored, or made available by other users or other third parties, or which is accessible through or may be located using our Products (collectively, “Third Party Content”) are those of the respective authors or producers and not of us or our shareholders, directors, officers, employees, agents, or representatives.

We do not control Third Party Content and do not guarantee the accuracy, integrity or quality of such Third Party Content. We are not responsible for the performance of, we do not endorse, and we are not responsible or liable for, any Third Party Content or any information or materials advertised in any Third Party Content. By using our Products, you may be exposed to content that is offensive, indecent, or objectionable. We are not responsible or liable, directly or indirectly, for any damage or loss caused to you by your use of or reliance on any goods, services, or information available on or through any third party service or Third Party Content. It is your responsibility to evaluate the information, opinion, advice, or other content available on and through our Products.

Proprietary Rights

John Snow Labs will not obtain any rights under this EULA from you (or your licensors) to your content.

The Products, including software, is and remains the exclusive property of John Snow Labs and its licensors. Except for the access and use rights expressly set forth in this EULA, no license or other rights in or to the Products or John Snow Labs trademark(s) and other intellectual property rights therein, are granted to you, and all such licenses and rights are expressly reserved. You will not remove, alter, or obscure any proprietary notices (including copyright and trademark notices) on any portion of our Products or any Content.

Trademarks

“John Snow Labs,” the John Snow Labs logo, and any other product, business or service name or slogan, whether registered or pending, displayed on our Products are trademarks of John Snow Labs, Inc. or its suppliers or licensors, and may not be copied, imitated or used, in whole or in part, without the prior written permission of John Snow Labs or the applicable trademark holder. You may not use any metatags or any other “hidden text” utilizing “John Snow Labs” or any other name, trademark or product, business or service name of John Snow Labs without our prior written permission. In addition, the look and feel of our Products, including all page headers, custom graphics, button icons and scripts, is the service mark, trademark and/or trade dress of John Snow Labs and may not be copied, imitated or used, in whole or in part, without our prior written permission. All other trademarks, pending trademarks, registered trademarks, product names and company names or logos mentioned in our Products are the property of John Snow Labs Inc. and/or their respective owners. Reference to any products, services, processes or other information, by trade name, trademark, manufacturer, supplier, or otherwise does not constitute or imply endorsement, sponsorship, or recommendation thereof by us.

Disclaimer of Warranties

YOUR USE OF THE PRODUCTS IS AT YOUR SOLE RISK. THE PRODUCTS AND CONTENT EACH ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. WE AND OUR SUPPLIERS AND LICENSORS EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NON-INFRINGEMENT. WE DO NOT GUARANTEE THE ACCURACY, COMPLETENESS, OR USEFULNESS OF THE PRODUCTS OR ANY CONTENT, AND YOU RELY ON THE PRODUCTS AND CONTENT AT YOUR OWN RISK. ANY MATERIAL THAT YOU ACCESS OR OBTAIN THROUGH OUR PRODUCTS IS DONE AT YOUR OWN DISCRETION AND RISK AND YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OF ANY MATERIAL THROUGH OUR PRODUCTS. NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED BY YOU FROM US OR THROUGH OR FROM OUR PRODUCTS WILL CREATE ANY WARRANTY NOT EXPRESSLY STATED IN THIS EULA. SOME STATES MAY PROHIBIT A DISCLAIMER OF WARRANTIES AND YOU MAY HAVE OTHER RIGHTS THAT VARY FROM STATE TO STATE.

Limitation of Liability

WE AND OUR SUPPLIERS AND LICENSORS WILL NOT BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO, DAMAGES FOR LOSS OF PROFITS, GOODWILL, USE, DATA, OR OTHER INTANGIBLE LOSSES (EVEN IF WE HAVE BEEN ADVISED OF THE POSSIBILITY OF THESE DAMAGES), RESULTING FROM YOUR USE OF OUR PRODUCTS AND CONTENT. UNDER NO CIRCUMSTANCES WILL THE TOTAL LIABILITY OF US AND OUR SUPPLIERS AND LICENSORS OF ALL KINDS ARISING OUT OF OR RELATED TO YOUR USE OF THE PRODUCTS AND CONTENT (INCLUDING BUT NOT LIMITED TO WARRANTY CLAIMS), REGARDLESS OF THE FORUM AND REGARDLESS OF WHETHER ANY ACTION OR CLAIM IS BASED ON CONTRACT, TORT, OR OTHERWISE, EXCEED THE AMOUNTS, IF ANY, THAT YOU HAVE PAID FOR YOUR USE OF THE PRODUCTS AND CONTENT. BECAUSE SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR CONSEQUENTIAL OR INCIDENTAL DAMAGES, THE ABOVE LIMITATION MAY NOT APPLY TO YOU.

Indemnity

To the full extent permitted by applicable law, you shall defend, indemnify and hold harmless John Snow Labs, its affiliates and its licensors, and each of their respective employees, officers, directors, and representatives from and against any claims, damages, losses, liabilities, costs, and expenses (including reasonable attorney’s fees) arising out of or relating to any third party claim concerning: (a) your use of the Products; (b) breach of this EULA or violation of applicable law by you; (c) any content or the combination of such content with other software, content or processes, including any claim involving alleged infringement or misappropriation of third-party rights by such content or combination; or (d) breach of any obligation or duty you owe to a third party.

Legal Notices

Enforcement of this EULA will be governed by the laws of the State of Delaware, excluding its conflict and choice of law principles. The exclusive jurisdiction and venue for any claims arising out of or related to this EULA or your use of the Products will lie in the state and federal courts located in Sussex County, within the State of Delaware, and you irrevocably agree to submit to the jurisdiction of such courts. Our failure to enforce any right or provision in this EULA will not constitute a waiver of such right or provision unless acknowledged and agreed by us in writing. In the event that a court of competent jurisdiction finds any provision of this EULA to be illegal, invalid, or unenforceable, the remaining provisions will remain in full force and effect.

Notifications

We may use your contact information to notify you if we have any legitimate interest or if we need to notify you on any important information related to your use of Products. We will not send you newsletters unless you expressly consented to such notifications.

Contacting Us

If you have any questions or concerns about our Products or this EULA, you may contact us by email at support@JohnSnowLabs.com.

Description

The Inpatient Psychiatric Hospital Facility Quality Reporting (IPFQR) program is being developed as mandated by section 1886(s)(4) of the Social Security Act (SSA), as added and amended by Sections 3401(f) and 10322(a) of the Affordable Care Act (Pub.L. 111-148).
The IPFQR program is a pay-for-reporting program intended to equip consumers with quality of care information to make more informed decisions about healthcare options. It is also intended to encourage hospitals and clinicians to improve the quality of inpatient care provided to beneficiaries by, first, ensuring that providers are aware of and reporting on best practices for their respective facilities and type of care. Because this is a pay-for-reporting program, facilities will be subject to payment reduction for non-participation. Eligible hospitals that do not participate in the IPFQR program in a fiscal year will receive a 2.0 percentage point reduction to their annual update to their standard federal rate for that year. The reduction is noncumulative across payment years.

The IPFQR program requires facilities to submit data for specific inpatient psychiatric clinical process measures. These quality measures will be announced no later than October 1, 2012. To meet the IPFQR program requirement, Inpatient Psychiatric Hospital Facilities (IPFs) will be required to submit all quality measures in the form, manner, and time as specified by the Secretary, to the Centers for Medicare & Medicaid Services (CMS), beginning with Fiscal Year (FY) 2014 payment determination year and subsequent fiscal years. Participating IPFs must comply with the program requirements, which will be set forth through rule-making, including public reporting of the measure rates.

About this Dataset

Data Info

Date Created

2014-01-28

Last Modified

2022-10-04

Version

2022-10-26

Update Frequency

Quarterly

Temporal Coverage

2014-2022

Spatial Coverage

United States

Source

John Snow Labs; Centers for Medicare & Medicaid Services;

Source License URL

Source License Requirements

N/A

Source Citation

N/A

Keywords

Quality Reporting Programs, Quality Reporting Payments, Quality of Care Information, Eligible Psychiatric Hospitals, Psychiatric Hospital, Psychiatric Services, CMS Hospital Compare, Psychiatric Hospital Facilities

Other Titles

Psychiatric Hospital Compare Data, Inpatient Hospital Quality Measures, CMS Quality Measures Data, IPQRF Program Quality Measures, Inpatient Psychiatric Hospital Facility Quality Measures, Inpatient Psychiatric Hospital Facility Quality Reporting Program

Data Fields

Name Description Type Constraints
YearIndicates the reporting year.date-
National_HBIPS2_Measure_DescriptionDescription of Hospital Based Inpatient Psychiatric Services Core Measure Set. HBIPS2 is described as Hours of Physical Restraint Use. Total hours all patients spent in physical restraint as a proportion of total inpatient hours.string-
National_HBIPS2_Overall_Rate_Per_1000Indicates the overall rate per 1000 for HBIPS2 Measure.numberlevel : Ratio
National_HBIPS2_Overall_NumeratorIndicates the overall Numerator value for HBIPS2 Measure.numberlevel : Ratio
National_HBIPS2_Overall_DenominatorIndicates the overall Denominator value for HBIPS2 Measure.integerlevel : Ratio
National_HBIPS2_1_to_12_Rate_Per_1000Indicates the HBIPS2 Measure Rate per 1000 for children (1-12 Years)numberlevel : Ratio
National_HBIPS2_1_to_12_NumeratorIndicates the Numerator values for HBIPS2 Measure for children (1-12 Years)numberlevel : Ratio
National_HBIPS2_1_to_12_DenominatorIndicates the Denominator values for HBIPS2 Measure for children (1-12 Years)integerlevel : Ratio
National_HBIPS2_13_to_17_Rate_Per_1000Indicates the HBIPS2 Measure Rate per 1000 for Adolescent (13-17 Years).numberlevel : Ratio
National_HBIPS2_13_to_17_NumeratorIndicates the Numerator values for HBIPS2 Measure for Adolescent (13-17 Years).numberlevel : Ratio
National_HBIPS2_13_to_17_DenominatorIndicates the Denominator values for HBIPS2 Measure for Adolescent (13-17 Years).integerlevel : Ratio
National_HBIPS2_18_to_64_Rate_Per_1000Indicates the HBIPS2 Measure Rate per 1000 for Adult (18-64 Years).numberlevel : Ratio
National_HBIPS2_18_to_64_NumeratorIndicates the Numerator values for HBIPS2 Measure for Adult (18-64 Years).numberlevel : Ratio
National_HBIPS2_18_to_64_DenominatorIndicates the Denominator values for HBIPS2 Measure for Adult (18-64 Years).integerlevel : Ratio
National_HBIPS2_65_Over_Rate_Per_1000Indicates the HBIPS2 Measure Rate per 1000 for Older Adult (> 65 Years).numberlevel : Ratio
National_HBIPS2_65_Over_NumeratorIndicates the Numerator values for HBIPS2 Measure for Older Adult (> 65 Years).numberlevel : Ratio
National_HBIPS2_65_Over_DenominatorIndicates the Denominator values for HBIPS2 Measure for Older Adult (> 65 Years).integerlevel : Ratio
National_HBIPS3_Measure_DescriptionDescription of Hospital Based Inpatient Psychiatric Services Core Measure Set. HBIPS3 is described as Hours of Seclusion Use. Total hours all patients spent in seclusion as a proportion of total inpatient hours.string-
National_HBIPS3_Overall_Rate_Per_1000Indicates the Numerator values for HBIPS3 Measure for children (1-12 Years)numberlevel : Ratio
National_HBIPS3_Overall_NumeratorIndicates the Numerator values for HBIPS3 Measure for children (1-12 Years)numberlevel : Ratio
National_HBIPS3_Overall_DenominatorIndicates the Numerator values for HBIPS3 Measure for children (1-12 Years)numberlevel : Ratio
National_HBIPS3_1_to_12_Rate_Per_1000Indicates the HBIPS3 Measure Rate per 1000 for children (1-12 Years)numberlevel : Ratio
National_HBIPS3_1_to_12_NumeratorIndicates the Numerator values for HBIPS3 Measure for children (1-12 Years)numberlevel : Ratio
National_HBIPS3_1_to_12_DenominatorIndicates the Denominator values for HBIPS3 Measure for children (1-12 Years)integerlevel : Ratio
National_HBIPS3_13_to_17_Rate_Per_1000Indicates the HBIPS3 Measure Rate per 1000 for Adolescent (13-17 Years).numberlevel : Ratio
National_HBIPS3_13_to_17_NumeratorIndicates the Numerator values for HBIPS3 Measure for Adolescent (13-17 Years).numberlevel : Ratio
National_HBIPS3_13_to_17_DenominatorIndicates the Denominator values for HBIPS3 Measure for Adolescent (13-17 Years).integerlevel : Ratio
National_HBIPS3_18_to_64_Rate_Per_1000Indicates the HBIPS3 Measure Rate per 1000 for Adult (18-64 Years).numberlevel : Ratio
National_HBIPS3_18_to_64_NumeratorIndicates the Numerator values for HBIPS3 Measure for Adult (18-64 Years).numberlevel : Ratio
National_HBIPS3_18_to_64_DenominatorIndicates the Denominator values for HBIPS3 Measure for Adult (18-64 Years).integerlevel : Ratio
National_HBIPS3_65_Over_Rate_Per_1000Indicates the HBIPS3 Measure Rate per 1000 for Older Adult (> 65 Years).numberlevel : Ratio
National_HBIPS3_65_Over_NumeratorIndicates the Numerator values for HBIPS3 Measure for Older Adult (> 65 Years).numberlevel : Ratio
National_HBIPS3_65_Over_DenominatorIndicates the Denominator values for HBIPS3 Measure for Older Adult (> 65 Years).integerlevel : Ratio
National_HBIPS4_Measure_DescriptionDescription of Hospital Based Inpatient Psychiatric Services Core Measure Set. HBIPS4 is described as Patients discharged on multiple antipsychotic medications.string-
National_HBIPS4_Overall_Percent_of_TotalIndicates the overall percentage for HBIPS4 Measure.numberlevel : Ratio
National_HBIPS4_Overall_NumeratorIndicates the overall Numerator value for HBIPS4 Measure.integerlevel : Ratio
National_HBIPS4_Overall_DenominatorIndicates the overall Denominator value for HBIPS4 Measure.integerlevel : Ratio
National_HBIPS4_1_to_12_Percent_of_TotalIndicates the overall percentage of HBIPS4 Measure for children (1-12 Years)numberlevel : Ratio
National_HBIPS4_1_to_12_NumeratorIndicates the Numerator values for HBIPS4 Measure for children (1-12 Years)integerlevel : Ratio
National_HBIPS4_1_to_12_DenominatorIndicates the Denominator values for HBIPS4 Measure for children (1-12 Years)integerlevel : Ratio
National_HBIPS4_13_to_17_Percent_of_TotalIndicates the overall percentage of HBIPS4 Measure for Adolescent (13-17 Years).numberlevel : Ratio
National_HBIPS4_13_to_17_NumeratorIndicates the Numerator values for HBIPS4 Measure for Adolescent (13-17 Years).integerlevel : Ratio
National_HBIPS4_13_to_17_DenominatorIndicates the Denominator values for HBIPS4 Measure for Adolescent (13-17 Years).integerlevel : Ratio
National_HBIPS4_18_to_64_Percent_of_TotalIndicates the overall percentage of HBIPS4 Measure for Adult (18-64 Years).numberlevel : Ratio
National_HBIPS4_18_to_64_NumeratorIndicates the Numerator values for HBIPS4 Measure for Adult (18-64 Years).integerlevel : Ratio
National_HBIPS4_18_to_64_DenominatorIndicates the Denominator values for HBIPS4 Measure for Adult (18-64 Years).integerlevel : Ratio
National_HBIPS4_65_Over_Percent_of_TotalIndicates the overall percentage of HBIPS4 Measure for Older Adult (> 65 Years).numberlevel : Ratio
National_HBIPS4_65_Over_NumeratorIndicates the Numerator values for HBIPS4 Measure for Older Adult (> 65 Years).integerlevel : Ratio
National_HBIPS4_65_Over_DenominatorIndicates the Denominator values for HBIPS4 Measure for Older Adult (> 65 Years).integerlevel : Ratio
National_HBIPS5_Measure_DescriptionDescription of Hospital Based Inpatient Psychiatric Services Core Measure Set. HBIPS5 is described as Patients discharged on multiple antipsychotic medications with appropriate justification.Percent of patients discharged on multiple antipsychotic medications with appropriate justification as a proportion of patients discharged on two or more antipsychotic medications. Appropriate justifications are limited to augmentation of clozapine, tapering to monotherapy, and history of at least three failed trials of monotherapy.string-
National_HBIPS5_Overall_Percent_of_TotalIndicates the overall percentage for HBIPS5 Measure.numberlevel : Ratio
National_HBIPS5_Top_10_PercentIndicates the top 10 percentage for HBIPS5 Measure.integerlevel : Ratio
National_HBIPS5_Overall_NumeratorIndicates the overall Numerator value for HBIPS5 Measure.integerlevel : Ratio
National_HBIPS5_Overall_DenominatorIndicates the overall Denominator value for HBIPS5 Measure.integerlevel : Ratio
National_HBIPS5_1_to_12_Percent_of_TotalIndicates the overall percentage of HBIPS5 Measure for children (1-12 Years)numberlevel : Ratio
National_HBIPS5_1_to_12_NumeratorIndicates the Numerator values for HBIPS5 Measure for children (1-12 Years)integerlevel : Ratio
National_HBIPS5_1_to_12_DenominatorIndicates the Denominator values for HBIPS5 Measure for children (1-12 Years)integerlevel : Ratio
National_HBIPS5_13_to_17_Percent_of_TotalIndicates the overall percentage of HBIPS5 Measure for Adolescent (13-17 Years).numberlevel : Ratio
National_HBIPS5_13_to_17_NumeratorIndicates the Numerator values for HBIPS5 Measure for Adolescent (13-17 Years).integerlevel : Ratio
National_HBIPS5_13_to_17_DenominatorIndicates the Denominator values for HBIPS5 Measure for Adolescent (13-17 Years).integerlevel : Ratio
National_HBIPS5_18_to_64_Percent_of_TotalIndicates the overall percentage of HBIPS5 Measure for Adult (18-64 Years).numberlevel : Ratio
National_HBIPS5_18_to_64_NumeratorIndicates the Numerator values for HBIPS5 Measure for Adult (18-64 Years).integerlevel : Ratio
National_HBIPS5_18_to_64_DenominatorIndicates the Denominator values for HBIPS5 Measure for Adult (18-64 Years).integerlevel : Ratio
National_HBIPS5_65_Over_Percent_of_TotalIndicates the overall percentage of HBIPS5 Measure for Older Adult (> 65 Years).numberlevel : Ratio
National_HBIPS5_65_Over_NumeratorIndicates the Numerator values for HBIPS5 Measure for Older Adult (> 65 Years).integerlevel : Ratio
National_HBIPS5_65_Over_DenominatorIndicates the Denominator values for HBIPS5 Measure for Older Adult (> 65 Years).integerlevel : Ratio
National_HBIPS6_Measure_DescriptionDescription of Hospital Based Inpatient Psychiatric Services Core Measure Set. HBIPS6 is described as Post discharge continuing care plan created.string-
National_HBIPS6_Overall_Percent_of_TotalIndicates the overall percentage for HBIPS6 Measure.numberlevel : Ratio
National_HBIPS6_Overall_NumeratorIndicates the overall Numerator value for HBIPS6 Measure.integerlevel : Ratio
National_HBIPS6_Overall_DenominatorIndicates the overall Denominator value for HBIPS6 Measure.integerlevel : Ratio
National_HBIPS6_1_to_12_Percent_of_TotalIndicates the overall percentage of HBIPS6 Measure for children (1-12 Years)numberlevel : Ratio
National_HBIPS6_1_to_12_NumeratorIndicates the Numerator values for HBIPS6 Measure for children (1-12 Years)integerlevel : Ratio
National_HBIPS6_1_to_12_DenominatorIndicates the Denominator values for HBIPS6 Measure for children (1-12 Years)integerlevel : Ratio
National_HBIPS6_13_to_17_Percent_of_TotalIndicates the overall percentage of HBIPS6 Measure for Adolescent (13-17 Years).numberlevel : Ratio
National_HBIPS6_13_to_17_NumeratorIndicates the Numerator values for HBIPS6 Measure for Adolescent (13-17 Years).integerlevel : Ratio
National_HBIPS6_13_to_17_DenominatorIndicates the Denominator values for HBIPS6 Measure for Adolescent (13-17 Years).integerlevel : Ratio
National_HBIPS6_18_to_64_Percent_of_TotalIndicates the overall percentage of HBIPS6 Measure for Adult (18-64 Years).numberlevel : Ratio
National_HBIPS6_18_to_64_NumeratorIndicates the Numerator values for HBIPS6 Measure for Adult (18-64 Years).integerlevel : Ratio
National_HBIPS6_18_to_64_DenominatorIndicates the Denominator values for HBIPS6 Measure for Adult (18-64 Years).integerlevel : Ratio
National_HBIPS6_65_Over_Percent_of_TotalIndicates the overall percentage of HBIPS6 Measure for Older Adult (> 65 Years).numberlevel : Ratio
National_HBIPS6_65_Over_NumeratorIndicates the Numerator values for HBIPS6 Measure for Older Adult (> 65 Years).numberlevel : Ratio
National_HBIPS6_65_Over_DenominatorIndicates the Denominator values for HBIPS6 Measure for Older Adult (> 65 Years).integerlevel : Ratio
National_HBIPS7_Measure_DescriptionDescription of Hospital Based Inpatient Psychiatric Services Core Measure Set. HBIPS7 is described as Post discharge continuing care plan transmitted to next level of care provider upon discharge.string-
National_HBIPS7_Overall_Percent_of_TotalIndicates the overall percentage for HBIPS7 Measure.numberlevel : Ratio
National_HBIPS7_Overall_NumeratorIndicates the overall Numerator value for HBIPS7 Measure.integerlevel : Ratio
National_HBIPS7_Overall_DenominatorIndicates the overall Denominator value for HBIPS7 Measure.integerlevel : Ratio
National_HBIPS7_1_to_12_Percent_of_TotalIndicates the overall percentage of HBIPS7 Measure for children (1-12 Years)numberlevel : Ratio
National_HBIPS7_1_to_12_NumeratorIndicates the Numerator values for HBIPS7 Measure for children (1-12 Years)integerlevel : Ratio
National_HBIPS7_1_to_12_DenominatorIndicates the Denominator values for HBIPS7 Measure for children (1-12 Years)integerlevel : Ratio
National_HBIPS7_13_to_17_Percent_of_TotalIndicates the overall percentage of HBIPS7 Measure for Adolescent (13-17 Years).numberlevel : Ratio
National_HBIPS7_13_to_17_NumeratorIndicates the Numerator values for HBIPS7 Measure for Adolescent (13-17 Years).integerlevel : Nominal
National_HBIPS7_13_to_17_DenominatorIndicates the Denominator values for HBIPS7 Measure for Adolescent (13-17 Years).integerlevel : Nominal
National_HBIPS7_18_to_64_Percent_of_TotalIndicates the overall percentage of HBIPS7 Measure for Adult (18-64 Years).numberlevel : Ratio
National_HBIPS7_18_to_64_NumeratorIndicates the Numerator values for HBIPS7 Measure for Adult (18-64 Years).integerlevel : Ratio
National_HBIPS7_18_to_64_DenominatorIndicates the Denominator values for HBIPS7 Measure for Adult (18-64 Years).integerlevel : Ratio
National_HBIPS7_65_Over_Percent_of_TotalIndicates the overall percentage of HBIPS7 Measure for Older Adult (> 65 Years).numberlevel : Ratio
National_HBIPS7_65_Over_NumeratorIndicates the Numerator values for HBIPS7 Measure for Older Adult (> 65 Years).integerlevel : Ratio
National_HBIPS7_65_Over_DenominatorIndicates the Denominator values for HBIPS7 Measure for Older Adult (> 65 Years)..integerlevel : Ratio
National_SMD_Measure_DescriptionDescription of Screening for Metabolic Disorders (SMD) Measure.string-
National_SMD_PercentIndicates the overall percentage for Screening for Metabolic Disorders (SMD) Measure.integerlevel : Ratio
National_SMD_Top_10_PercentIndicates the top 10 percentage of Screening for Metabolic Disorders (SMD) Measure.integerlevel : Ratio
National_SUB1_Measure_DescriptionDescription of Substance Use Treatment Measure. SUB1 is described as Alcohol Use Screening. Measures the percent of patients age 18 years or older who were screened for alcohol use, using a validated screening questionnaire for unhealthy alcohol use within three days of admission as a proportion of patients discharged.string-
National_SUB1_PercentIndicates the overall percentage for SUB1 Measure.numberlevel : Ratio
National_SUB1_Top_10_PercentIndicates the top 10 percentage for SUB1 Measure.integerlevel : Ratio
National_SUB1_NumeratorIndicates the overall Numerator value for SUB1 Measure.integerlevel : Ratio
National_SUB1_DenominatorIndicates the overall Denominator value for SUB1 Measure.integerlevel : Ratio
National_SUB2_2a_Measure_DescriptionDescription of Substance Use Treatment Measure. It is described as Alcohol Use Brief Intervention Provided or Offered.string-
National_SUB2_PercentIndicates the overall percentage for SUB2 Measure.numberlevel : Ratio
National_SUB2_Top_10_PercentIndicates the top 10 percentage for SUB2 Measure.integerlevel : Ratio
National_SUB2_NumeratorIndicates the overall percentage for SUB2 Measure.numberlevel : Ratio
National_SUB2_DenominatorIndicates the overall Denominator value for SUB2 Measure.integerlevel : Ratio
National_SUB2a_PercentIndicates the overall percentage for SUB2a Measure.numberlevel : Ratio
National_SUB2a_Top_10_PercentIndicates the top 10 percentage for SUB2 Measure.integerlevel : Ratio
National_SUB2a_NumeratorIndicates the overall Numerator value for SUB2a Measure.integerlevel : Ratio
National_SUB2a_DenominatorIndicates the overall Denominator value for SUB2a Measure.integerlevel : Ratio
National_SUB3_3a_Measure_DescriptionDescription of National-wise Substance Use Treatment Measure. SUB3 3a is described as use of Alcohol and other Drug Use Disorder Treatment Provided or Offered at Discharge.string-
National_SUB3_PercentIndicates the overall percentage for SUB3 Measure.integerlevel : Ratio
National_SUB3_Top_10_PercentIndicates the top 10 percentage for SUB3 Measure.integerlevel : Ratio
National_SUB3a_PercentIndicates the overall percentage for SUB3a Measure.integerlevel : Ratio
National_SUB3a_Top_10_PercentIndicates the top 10 percentage for SUB3a Measure.integerlevel : Ratio
National_TOB1_Measure_DescriptionDescription of Substance Use Treatment Measure. TOB1 is described as Tobacco Use Screening. Measures the percent of patients age 18 years or older who were screened for tobacco use, using a validated screening questionnaire for unhealthy tobacco use within three days of admission as a proportion of patients discharged.string-
National_TOB1_PercentIndicates the overall percentage for TOB1 Measure.numberlevel : Ratio
National_TOB1_Top_10_PercentIndicates the top 10 percentage for TOB1 Measure.integerlevel : Ratio
National_TOB1_NumeratorIndicates the overall Numerator value for TOB1 Measure.integerlevel : Ratio
National_TOB1_DenominatorIndicates the overall Denominator value for TOB1 Measure.integerlevel : Ratio
National_TOB2_2a_Measure_DescriptionDescription of Substance Use Treatment Measure. It is described as National Tobacco Use Treatment during the hospital stay.string-
National_TOB2_PercentIndicates the overall percentage for TOB2 Measure.numberlevel : Ratio
National_TOB2_Top_10_PercentIndicates the top 10 percentage for TOB2 Measure.integerlevel : Ratio
National_TOB2_NumeratorIndicates the overall Numerator value for TOB2 Measure.integerlevel : Ratio
National_TOB2_DenominatorIndicates the overall Denominator value for TOB2 Measure.integerlevel : Ratio
National_TOB2a_PercentIndicates the overall percentage for TOB2 Measure.numberlevel : Ratio
National_TOB2a_Top_10_PercentIndicates the top 10 percentage for TOB2 Measure.integerlevel : Ratio
National_TOB2a_NumeratorIndicates the overall Numerator value for TOB2a Measure.integerlevel : Ratio
National_TOB2a_DenominatorIndicates the overall Denominator value for TOB2a Measure.integerlevel : Ratio
National_TOB3_3a_Measure_DescriptionDescription of Substance Use Treatment Measure. It is described as National Tobacco Use Treatment provided or Offered at Discharge.string-
National_TOB3_PercentIndicates the overall percentage for TOB3 Measure.numberlevel : Ratio
National_TOB3_Top_10_PercentIndicates the top 10 percentage for TOB3 Measure.integerlevel : Ratio
National_TOB3_NumeratorIndicates the overall Numerator value for TOB3 Measure.integerlevel : Ratio
National_TOB3_DenominatorIndicates the overall Denominator value for TOB3 Measure.integerlevel : Ratio
National_TOB3a_PercentIndicates the overall percentage for TOB3 Measure.numberlevel : Ratio
National_TOB3a_Top_10_PercentIndicates the top 10 percentage for TOB3a Measure.integerlevel : Ratio
National_TOB3a_NumeratorIndicates the overall Numerator value for TOB3a Measure.integerlevel : Ratio
National_TOB3a_DenominatorIndicates the overall Denominator value for TOB3a Measure.integerlevel : Ratio
National_PEoC_Measure_DescriptionDescription of Patient Experience of Care Measure. PEOC is a structural measure. This is a mandatory attestation: does the facility routinely assess patient experience of care using a standardized collection protocol and a structured instrument, and if yes, which tool did they use.string-
National_PEoC_Yes_CountIndicates the number of 'Yes' counts for Patient Experience of care Measure.integerlevel : Ratio
National_PEoC_No_CountIndicates the number of 'No' counts for Patient Experience of care Measure.integerlevel : Ratio
National_PEoC_Yes_PercentIndicates the Percent of 'Yes' for Patient Experience of care Measure.numberlevel : Ratio
National_PEoC_No_PercentIndicates the Percent of 'No' for Patient Experience of care Measure.numberlevel : Ratio
National_EHR_Use_Measure_DescriptionDescription of facility's highest level typical use of an Electronic Health Records (EHR) Measure. EHR is a structural measure. This is a mandatory attestation: identify the degree to which the facility employs EHR systems in their service program and use such systems to support health information exchange at times of transitions in care.string-
National_EHR_Paper_CountIndicates the number of 'Paper' Records as per Electronic Health Record Measure.integerlevel : Ratio
National_EHR_Non_Certified_CountIndicates the number of 'Non-Certified' Records as per Electronic Health Record Measure.integerlevel : Ratio
National_EHR_Certified_CountIndicates the number of 'Certified' Records as per Electronic Health Record Measure.integerlevel : Ratio
National_EHR_Paper_PercentIndicates the Percent of 'Paper' Records as per Electronic Health Record Measure.numberlevel : Ratio
National_EHR_Non_Certified_PercentIndicates the Percent of 'Non-Certified' Records as per Electronic Health Record Measurenumberlevel : Ratio
National_EHR_Certified_PercentIndicates the Percent of 'Certified' Records as per Electronic Health Record Measurenumberlevel : Ratio
National_EHR_HISP_Measure_DescriptionDescription of Facility exchanged interoperable health information with a health information service provider (HISP) at times of transitions in care.string-
National_EHR_HISP_Yes_CountIndicates the number of 'Yes' counts for Electronic Health Record (EHR) Health Information Service Provider (HISP) Measure.integerlevel : Ratio
National_EHR_HISP_No_CountIndicates the number of 'No' counts for Electronic Health Record (EHR) Health Information Service Provider (HISP) Measure.integerlevel : Ratio
National_EHR_HISP_Yes_PercentIndicates the percent of 'Yes' for Electronic Health Record (EHR) Health Information Service Provider (HISP) Measure.integerlevel : Ratio
National_EHR_HISP_No_PercentIndicates the percent of 'No' for Electronic Health Record (EHR) Health Information Service Provider (HISP) Measure.integerlevel : Ratio
National_HIE_Measure_DescriptionDescription of Health Information Exchange Measure. Used at times of transitions in care.string-
National_HIE_Yes_CountIndicates the number of 'Yes' counts for Health Information Exchange Measure.integerlevel : Ratio
National_HIE_No_CountIndicates the number of 'No' counts for Health Information Exchange Measure.integerlevel : Ratio
National_HIE_Yes_PercentIndicates the Percent of 'Yes' for Health Information Exchange Measure.numberlevel : Ratio
National_HIE_No_PercentIndicates the Percent of 'No' for Health Information Exchange Measure.numberlevel : Ratio
National_HIE_Start_DateThe first day of HIE data measures was collected. The date format is YYYY-MM-DD.date-
National_HIE_End_DateThe last day of HIE data measures was collected. The date format is YYYY-MM-DD.date-
National_TR1_Measure_DescriptionDescription of Transition record with specified elements received by discharged patients (TR1).string-
National_TR1_PercentIndicates the percentage of Transition Record with specified elements (TR1) Measure.integerlevel : Ratio
National_TR1_Top_10_PercentIndicates the top 10 percentage for Transition Record with specified elements (TR1) Measure.integerlevel : Ratio
National_TR2_Measure_DescriptionDescription of Timely Transmission of transition record (TR2) Measure.string-
National_TR2_PercentIndicates the percentage of Timely Transmission of transition record (TR2) Measure.integerlevel : Ratio
National_TR2_Top_10_PercentIndicates the top 10 percentage for Timely Transmission of transition record (TR2) Measure.integerlevel : Ratio
National_TR2_Start_DateThe first day of TR2 data measures was collected. The date format is YYYY-MM-DD.date-
National_TR2_End_DateThe last day of TR2 data measures was collected. The date format is YYYY-MM-DD.date-
National_FUH_Measure_DescriptionDescription of Follow-Up after Hospitalization (FUH) Measure. FUH for Mental Illness measures the percentage of discharged patients age 6 years or older who had an outpatient visit, an intensive outpatient encounter, or a partial hospitalization with a mental health practitioner, within 7 days and 30 days of discharge. CMS will calculate these measures based on Medicare claims data.string-
National_FUH30_PercentIndicates the percent for Follow-up after Hospitalization (FUH) for Mental Illness of 30-Days.numberlevel : Ratio
National_FUH30_Top_10_PercentIndicates the top 10 percentage for Follow-up after Hospitalization (FUH) for Mental Illness of 30-Days.numberlevel : Ratio
National_FUH7_PercentIndicates the percent for Follow-up after Hospitalization (FUH) for Mental Illness of 7-Days.numberlevel : Ratio
National_FUH7_Top_10_PercentIndicates the top 10 percntage for Follow-up after Hospitalization (FUH) for Mental Illness of 7-Days.numberlevel : Ratio
National_FUH_Measure_Start_DateThe first day of FUH data measures was collected. The date format is YYYY-MM-DD.date-
National_FUH_Measure_End_DateThe last day of FUH data measures was collected. The date format is YYYY-MM-DD.date-
National_MedCont_Measure_DescriptionIt is described as Medication Continuation Following Inpatient Psychiatric Discharge.string-
National_MedCont_PercentIndicates the overall percentage for MedCon Measure.numberlevel : Ratio
National_MedCont_Top_10_PercentIndicates the top 10 percentage for Medication Continuation (MedCont) Following Inpatient Psychiatric Discharge Measure.numberlevel : Ratio
National_MedCont_Measure_Start_DateThe first day the data regarding MedCont measures was collected. The date format is YYYY-MM-DD.date-
National_MedCont_Measure_End_DateThe last day the data regarding MedCont measures was collected. The date format is YYYY-MM-DD.date-
National_READM30_IPF_Measure_DescriptionDescription of Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF).string-
National_READM30_IPF_National_RateIndicates the national rate for Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF).numberlevel : Ratio
National_READM30_IPF_Number_IPFs_WorseIndicates the number of IPFs worse for rate of readmission after 30 days of discharge from hospital.integerlevel : Ratio
National_READM30_IPF_Number_IPFs_SameIndicates the Same number of IPFs for rate of readmission after 30 days of discharge from hospital.integerlevel : Ratio
National_READM30_IPF_Number_IPFs_BetterIndicates the number of IPFs Better for rate of readmission after 30 days of discharge from hospital.integerlevel : Ratio
National_READM30_IPF_Number_IPFs_Too_FewIndicates the number of IPFs Too Few for rate of readmission after 30 days of discharge from hospital.integerlevel : Ratio
National_READM30_IPF_Start_DateThe first day the data regarding READM30 IPF Measure was collected. The date format is YYYY-MM-DD.date-
National_READM30_IPF_End_DateThe last day the data regarding READM30 IPF Measure was collected. The date format is YYYY-MM-DD.date-
National_IMM2_Measure_DescriptionIndicates the description of National Influenza Immunization Measure.string-
National_IMM2_PercentIndicates the overall percentage for IMM2 Measure.numberlevel : Ratio
National_IMM2_Top_10_PercentIndicates the top 10 percentage for IMM2 Measure.integerlevel : Ratio
National_IMM2_NumeratorIndicates the overall Numerator value for IMM2 Measure.integerlevel : Ratio
National_IMM2_DenominatorIndicates the overall Denominator value for IMM2 Measure.integerlevel : Ratio
National_HCP_Measure_DescriptionIndicates the description of National Healthcare Personnel Influenza Vaccination Measure.string-
National_HCP_PercentIndicates the overall percentage for HCP Measure.numberlevel : Ratio
National_HCP_NumeratorIndicates the overall Numerator value for HCP Measure.integerlevel : Ratio
National_HCP_DenominatorIndicates the overall Denominator value for HCP Measure.integerlevel : Ratio
National_Flu_Season_Start_DateThe first day of the Flu Season data measures was collected. The date format is YYYY-MM-DD.date-
National_Flu_Season_End_DateThe last day of the Flu Season data measures was collected. The date format is YYYY-MM-DD.date-
National_IPFQR_HCP_COVID19_Measure_DescriptionIt describes inpatient psychiatric hospital facility quality measures percentage of healthcare personnel who completed COVID-19 primary vaccination series (IPFQR- HCP COVID-19).string-
National_IPFQR_HCP_COVID19_PercentIndicates the overall percentage for IPFQR HCP COVID19 Measure.numberlevel : Ratio
National_IPFQR_HCP_COVID19_Start_DateThe first day the data regarding IPFQR HCP COVID19 Measure was collected. The date format is YYYY-MM-DD.date-
National_IPFQR_HCP_COVID19_End_DateThe last day the data regarding IPFQR HCP COVID19 Measure was collected. The date format is YYYY-MM-DD.date-

Data Preview

YearNational HBIPS2 Measure DescriptionNational HBIPS2 Overall Rate Per 1000National HBIPS2 Overall NumeratorNational HBIPS2 Overall DenominatorNational HBIPS2 1 to 12 Rate Per 1000National HBIPS2 1 to 12 NumeratorNational HBIPS2 1 to 12 DenominatorNational HBIPS2 13 to 17 Rate Per 1000National HBIPS2 13 to 17 NumeratorNational HBIPS2 13 to 17 DenominatorNational HBIPS2 18 to 64 Rate Per 1000National HBIPS2 18 to 64 NumeratorNational HBIPS2 18 to 64 DenominatorNational HBIPS2 65 Over Rate Per 1000National HBIPS2 65 Over NumeratorNational HBIPS2 65 Over DenominatorNational HBIPS3 Measure DescriptionNational HBIPS3 Overall Rate Per 1000National HBIPS3 Overall NumeratorNational HBIPS3 Overall DenominatorNational HBIPS3 1 to 12 Rate Per 1000National HBIPS3 1 to 12 NumeratorNational HBIPS3 1 to 12 DenominatorNational HBIPS3 13 to 17 Rate Per 1000National HBIPS3 13 to 17 NumeratorNational HBIPS3 13 to 17 DenominatorNational HBIPS3 18 to 64 Rate Per 1000National HBIPS3 18 to 64 NumeratorNational HBIPS3 18 to 64 DenominatorNational HBIPS3 65 Over Rate Per 1000National HBIPS3 65 Over NumeratorNational HBIPS3 65 Over DenominatorNational HBIPS4 Measure DescriptionNational HBIPS4 Overall Percent of TotalNational HBIPS4 Overall NumeratorNational HBIPS4 Overall DenominatorNational HBIPS4 1 to 12 Percent of TotalNational HBIPS4 1 to 12 NumeratorNational HBIPS4 1 to 12 DenominatorNational HBIPS4 13 to 17 Percent of TotalNational HBIPS4 13 to 17 NumeratorNational HBIPS4 13 to 17 DenominatorNational HBIPS4 18 to 64 Percent of TotalNational HBIPS4 18 to 64 NumeratorNational HBIPS4 18 to 64 DenominatorNational HBIPS4 65 Over Percent of TotalNational HBIPS4 65 Over NumeratorNational HBIPS4 65 Over DenominatorNational HBIPS5 Measure DescriptionNational HBIPS5 Overall Percent of TotalNational HBIPS5 Top 10 PercentNational HBIPS5 Overall NumeratorNational HBIPS5 Overall DenominatorNational HBIPS5 1 to 12 Percent of TotalNational HBIPS5 1 to 12 NumeratorNational HBIPS5 1 to 12 DenominatorNational HBIPS5 13 to 17 Percent of TotalNational HBIPS5 13 to 17 NumeratorNational HBIPS5 13 to 17 DenominatorNational HBIPS5 18 to 64 Percent of TotalNational HBIPS5 18 to 64 NumeratorNational HBIPS5 18 to 64 DenominatorNational HBIPS5 65 Over Percent of TotalNational HBIPS5 65 Over NumeratorNational HBIPS5 65 Over DenominatorNational HBIPS6 Measure DescriptionNational HBIPS6 Overall Percent of TotalNational HBIPS6 Overall NumeratorNational HBIPS6 Overall DenominatorNational HBIPS6 1 to 12 Percent of TotalNational HBIPS6 1 to 12 NumeratorNational HBIPS6 1 to 12 DenominatorNational HBIPS6 13 to 17 Percent of TotalNational HBIPS6 13 to 17 NumeratorNational HBIPS6 13 to 17 DenominatorNational HBIPS6 18 to 64 Percent of TotalNational HBIPS6 18 to 64 NumeratorNational HBIPS6 18 to 64 DenominatorNational HBIPS6 65 Over Percent of TotalNational HBIPS6 65 Over NumeratorNational HBIPS6 65 Over DenominatorNational HBIPS7 Measure DescriptionNational HBIPS7 Overall Percent of TotalNational HBIPS7 Overall NumeratorNational HBIPS7 Overall DenominatorNational HBIPS7 1 to 12 Percent of TotalNational HBIPS7 1 to 12 NumeratorNational HBIPS7 1 to 12 DenominatorNational HBIPS7 13 to 17 Percent of TotalNational HBIPS7 13 to 17 NumeratorNational HBIPS7 13 to 17 DenominatorNational HBIPS7 18 to 64 Percent of TotalNational HBIPS7 18 to 64 NumeratorNational HBIPS7 18 to 64 DenominatorNational HBIPS7 65 Over Percent of TotalNational HBIPS7 65 Over NumeratorNational HBIPS7 65 Over DenominatorNational SMD Measure DescriptionNational SMD PercentNational SMD Top 10 PercentNational SUB1 Measure DescriptionNational SUB1 PercentNational SUB1 Top 10 PercentNational SUB1 NumeratorNational SUB1 DenominatorNational SUB2 2a Measure DescriptionNational SUB2 PercentNational SUB2 Top 10 PercentNational SUB2 NumeratorNational SUB2 DenominatorNational SUB2a PercentNational SUB2a Top 10 PercentNational SUB2a NumeratorNational SUB2a DenominatorNational SUB3 3a Measure DescriptionNational SUB3 PercentNational SUB3 Top 10 PercentNational SUB3a PercentNational SUB3a Top 10 PercentNational TOB1 Measure DescriptionNational TOB1 PercentNational TOB1 Top 10 PercentNational TOB1 NumeratorNational TOB1 DenominatorNational TOB2 2a Measure DescriptionNational TOB2 PercentNational TOB2 Top 10 PercentNational TOB2 NumeratorNational TOB2 DenominatorNational TOB2a PercentNational TOB2a Top 10 PercentNational TOB2a NumeratorNational TOB2a DenominatorNational TOB3 3a Measure DescriptionNational TOB3 PercentNational TOB3 Top 10 PercentNational TOB3 NumeratorNational TOB3 DenominatorNational TOB3a PercentNational TOB3a Top 10 PercentNational TOB3a NumeratorNational TOB3a DenominatorNational PEoC Measure DescriptionNational PEoC Yes CountNational PEoC No CountNational PEoC Yes PercentNational PEoC No PercentNational EHR Use Measure DescriptionNational EHR Paper CountNational EHR Non Certified CountNational EHR Certified CountNational EHR Paper PercentNational EHR Non Certified PercentNational EHR Certified PercentNational EHR HISP Measure DescriptionNational EHR HISP Yes CountNational EHR HISP No CountNational EHR HISP Yes PercentNational EHR HISP No PercentNational HIE Measure DescriptionNational HIE Yes CountNational HIE No CountNational HIE Yes PercentNational HIE No PercentNational HIE Start DateNational HIE End DateNational TR1 Measure DescriptionNational TR1 PercentNational TR1 Top 10 PercentNational TR2 Measure DescriptionNational TR2 PercentNational TR2 Top 10 PercentNational TR2 Start DateNational TR2 End DateNational FUH Measure DescriptionNational FUH30 PercentNational FUH30 Top 10 PercentNational FUH7 PercentNational FUH7 Top 10 PercentNational FUH Measure Start DateNational FUH Measure End DateNational MedCont Measure DescriptionNational MedCont PercentNational MedCont Top 10 PercentNational MedCont Measure Start DateNational MedCont Measure End DateNational READM30 IPF Measure DescriptionNational READM30 IPF National RateNational READM30 IPF Number IPFs WorseNational READM30 IPF Number IPFs SameNational READM30 IPF Number IPFs BetterNational READM30 IPF Number IPFs Too FewNational READM30 IPF Start DateNational READM30 IPF End DateNational IMM2 Measure DescriptionNational IMM2 PercentNational IMM2 Top 10 PercentNational IMM2 NumeratorNational IMM2 DenominatorNational HCP Measure DescriptionNational HCP PercentNational HCP NumeratorNational HCP DenominatorNational Flu Season Start DateNational Flu Season End DateNational IPFQR HCP COVID19 Measure DescriptionNational IPFQR HCP COVID19 PercentNational IPFQR HCP COVID19 Start DateNational IPFQR HCP COVID19 End Date
2017Hours of physical-restraint use0.36250637.9229102920Hours of seclusion use0.23155194.028425227.0Patients discharged on multiple antipsychotic medications with appropriate justification66100.0Screening for metabolic disorders (SMD)65.099.0Percent of patients screened for alcohol use using a validated screening questionnaire92.0100.0Alcohol use brief intervention provided or offered79.0100.072.0100.0Alcohol and other drug use disorder treatment provided or offered at discharge65.098.054.093.0Tobacco use screening96.0100.0Tobacco use treatment provided or offered80.0100.045.086.0Tobacco use treatment provided or offered at discharge54.097.015.057.0Patient experience of care (PEoC) routinely assessed using standardized collection protocol1256.0360.078.022.0Facility's highest level typical use of an electronic health records system (EHR)913.029.0674.056.02.042.0Facility exchanged interoperable health information with a health information service provider (HISP) at times of transitions in care632.0984.039.061.0Transition record with specified elements received by discharged patients (TR1)50.098.0Timely transmission of transition record (TR2)45.097.02017-01-012017-12-31Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness52.771.730.647.92016-07-01Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF)20.1177.01325.0109.081.02015-07-01Influenza immunization (IPFQR-IMM-2)82.0100.0Influenza vaccination coverage among healthcare personnel (HCP)82.02017-10-012018-03-31
2016Hours of physical-restraint use0.44261956.1624715119Hours of Seclusion0.29172196.024616982.0Patients discharged on multiple antipsychotic medicationsPatients discharged on multiple antipsychotic medications with appropriate justification5932436.055361.0Post-discharge continuing care plan createdPost-discharge continuing care plan transmitted to the next level of care provider upon dischargeAlcohol Use Screening92.0624222.0676190.0Alcohol Use Brief Intervention Provided or Offered70.0134155.093798.062.082857.0134155.0Tobacco Use Screening96.28711771.0739291.0Tobacco Use Treatment (during the hospital stay)76.0262770.0343764.041.12141343.0343764.0Tobacco Use Treatment Provided or Offered at Discharge41.0126539.0310586.09.4329296.0310586.0Assessment of Patient Experience of Care1243.0389.076.024.0Highest level typical use of an EHR system944.038.0650.057.842.3340.0Interoperable health information exchanged with HISP619.01013.037.9362.072016-01-012016-12-31Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness2015-07-01Influenza Immunization80.98406603.0502083.0Healthcare Personnel Influenza Vaccination80.0473974.0589537.02016-10-012017-03-31
2014Hours of physical-restraint use0.41322218.26324172600.255460.0897288.00.1912517.02791775.00.31176304.7623380645.01.0127936.415347552.0Hours of Seclusion0.21165774.032297340.00.010071.0892761.00.013009.02762143.00.0137813.023579741.00.04881.05062695.0Patients discharged on multiple antipsychotic medications9.057288.0607754.02.0586.027666.04.02353.059699.011.3944633.0392000.08.09716.0128389.0Patients discharged on multiple antipsychotic medications with appropriate justification3732451.088613.032.0322.01014.046.01732.03732.040.024925.062732.026.05472.021135.0Post-discharge continuing care plan created85.0766795.0904926.093.043381.046815.090.093500.0104039.085.0483601.0572025.080.0146313.0182047.0Post-discharge continuing care plan transmitted to the next level of care provider upon discharge78.0699089.0902065.086.040089.046807.083.086461.0104023.077.0440189.0571708.074.0132350.0179527.0Alcohol Use Screening71.0490784.0691196.0Alcohol Use Brief Intervention Provided or OfferedTobacco Use ScreeningTobacco Use Treatment (during the hospital stay)Tobacco Use Treatment Provided or Offered at DischargeAssessment of Patient Experience of Care1177.0450.072.028.0Highest level typical use of an EHR system1039.044.0544.063.862.733.0Interoperable health information exchanged with HISP477.01150.029.3270.682014-01-012014-12-31Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illnessInfluenza ImmunizationHealthcare Personnel Influenza Vaccination
2018Hours of physical-restraint use0.36250637.9229102920Hours of seclusion use0.23155194.028425227.0Patients discharged on multiple antipsychotic medications with appropriate justification66100.0Screening for metabolic disorders (SMD)65.099.0Percent of patients screened for alcohol use using a validated screening questionnaire92.0100.0Alcohol use brief intervention provided or offered79.0100.072.0100.0Alcohol and other drug use disorder treatment provided or offered at discharge65.098.054.093.0Tobacco use screening96.0100.0Tobacco use treatment provided or offered80.0100.045.086.0Tobacco use treatment provided or offered at discharge54.097.015.057.0Patient experience of care (PEoC) routinely assessed using standardized collection protocol1256.0360.078.022.0Facility's highest level typical use of an electronic health records system (EHR)913.029.0674.056.02.042.0Facility exchanged interoperable health information with a health information service provider (HISP) at times of transitions in care632.0984.039.061.0Transition record with specified elements received by discharged patients (TR1)50.098.0Timely transmission of transition record (TR2)45.097.02017-01-012017-12-31Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness52.771.730.647.92016-07-012016-07-31Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF)20.1177.01325.0109.081.02015-07-01Influenza immunization (IPFQR-IMM-2)82.0100.0Influenza vaccination coverage among healthcare personnel (HCP)82.02017-10-012018-03-31
2019Hours of physical-restraint use0.38245395.5526707181Hours of seclusion use0.29183881.026534482.0Patients discharged on multiple antipsychotic medications with appropriate justification61100.0Screening for metabolic disorders (SMD)74.0100.0Alcohol use brief intervention provided or offered83.0100.075.0100.0Alcohol and other drug use disorder treatment provided or offered at discharge70.0100.059.098.0Tobacco use treatment provided or offered81.0100.046.088.0Tobacco use treatment provided or offered at discharge57.099.018.071.0Transition record with specified elements received by discharged patients (TR1)63.099.0Timely transmission of transition record (TR2)55.098.02018-01-012018-12-31Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness49.969.227.745.22017-07-012018-06-30Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF)20.1154.01344.0106.090.02016-07-012018-06-30Influenza immunization (IPFQR-IMM-2)83.0100.02018-10-012019-03-31
2020Hours of physical-restraint use0.34232198.842869627428696274.0Hours of seclusion usePatients discharged on multiple antipsychotic medications with appropriate justification65100.0
2021Hours of physical-restraint use0.3230923.3732027727Hours of seclusion use0.29226282.032027727.0Patients discharged on multiple antipsychotic medications with appropriate justification64100.0Screening for metabolic disorders (SMD)77.0100.0Alcohol use brief intervention provided or offered79.0100.072.0100.0Alcohol and other drug use disorder treatment provided or offered at discharge75.0100.075.0100.0Tobacco use treatment provided or offered80.0100.045.089.0Tobacco use treatment provided or offered at discharge61.0100.022.083.0Transition record with specified elements received by discharged patients (TR1)69.0100.0Timely transmission of transition record (TR2)60.098.02020-01-012020-12-31Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness49.571.027.946.22019-07-012019-12-312020-10-012021-03-31
2022Hours of physical-restraint use0.26199420.4831872211Hours of seclusion use0.25193385.3331872211.0Patients discharged on multiple antipsychotic medications with appropriate justification64100.0Screening for metabolic disorders (SMD)77.0100.0Alcohol use brief intervention provided or offered79.0100.072.0100.0Alcohol and other drug use disorder treatment provided or offered at discharge75.0100.063.099.0Tobacco use treatment provided or offered81.0100.045.089.0Tobacco use treatment provided or offered at discharge61.099.021.083.0Transition record with specified elements received by discharged patients (TR1)69.0100.0Timely transmission of transition record (TR2)60.098.02020-01-012020-12-31Percent of patients receiving follow-up care within 30 days (FUH-30) or within 7 days (FUH-7) after hospitalization for mental illness49.571.027.946.22019-07-012019-12-01Medication Continuation Following Inpatient Psychiatric Discharge73.183.72018-07-012019-12-01Patients readmitted to any hospital within 30 days of discharge from the inpatient psychiatric facility (READM-30-IPF)20.2115.01354.059.0108.02018-07-012019-12-01Influenza immunization (IPFQR-IMM-2)79.0100.02020-10-012021-03-31Percentage of healthcare personnel who completed COVID-19 primary vaccination series (IPFQR-HCP COVID-19)90.02021-10-012021-12-31